These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 38628650)

  • 41. The Tam formula: A pilot study for a new treatment for melasma.
    Srivastava R; John AM; Tam A; Firoz BF
    J Cosmet Dermatol; 2021 Jul; 20(7):2168-2171. PubMed ID: 33206439
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Understanding Melasma-How Can Pharmacology and Cosmetology Procedures and Prevention Help to Achieve Optimal Treatment Results? A Narrative Review.
    Piętowska Z; Nowicka D; Szepietowski JC
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231404
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness of laser and topical tranexamic acid combination therapy in melasma: An updated systematic review and meta-analysis of randomized controlled trials.
    Khan QA; Abdi P; Farkouh C; Anthony MR; Chundru A; Amatul F; Parimi K; Santiago N; Farkouh M; Iram S; Khan A
    Lasers Med Sci; 2023 Jun; 38(1):139. PubMed ID: 37326860
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intradermal Injection of 100mg Tranexamic Acid Versus Topical 4% Hydroquinone for the Treatment of Melasma: A Randomized, Controlled Trial.
    Pazyar N; Dezfuly MB; Hadibarhaghtalab M; Parvar SY; Molavi SN; Mapar MA; Zeinali M
    J Clin Aesthet Dermatol; 2023 Jan; 16(1):35-40. PubMed ID: 36743976
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Successful short-term and long-term treatment of melasma and postinflammatory hyperpigmentation using vitamin C with a full-face iontophoresis mask and a mandelic/malic acid skin care regimen.
    Taylor MB; Yanaki JS; Draper DO; Shurtz JC; Coglianese M
    J Drugs Dermatol; 2013 Jan; 12(1):45-50. PubMed ID: 23377327
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of 755-nm alexandrite picosecond laser in melasma management.
    Pulumati A; Jaalouk D; Algarin YA; Nouri K
    Arch Dermatol Res; 2023 Dec; 316(1):60. PubMed ID: 38151661
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Double-blind, Placebo-controlled Trial to Evaluate the Effectiveness of
    Goh CL; Chuah SY; Tien S; Thng G; Vitale MA; Delgado-Rubin A
    J Clin Aesthet Dermatol; 2018 Mar; 11(3):14-19. PubMed ID: 29606995
    [No Abstract]   [Full Text] [Related]  

  • 48. Efficacy and safety of serial glycolic acid peels and a topical regimen in the treatment of recalcitrant melasma.
    Erbil H; Sezer E; Taştan B; Arca E; Kurumlu Z
    J Dermatol; 2007 Jan; 34(1):25-30. PubMed ID: 17204097
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical evaluation of a topical Unani pharmacopoeial formulation
    Salma ; Shamsi Y; Nikhat S; Manjhi M; Akhtar MW; Ahmad S
    Avicenna J Phytomed; 2023; 13(3):255-264. PubMed ID: 37654999
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of topical versus intradermal injection of Tranexamic Acid In Egyptian melasma Patients: A randomised clinical trial.
    Badran AY; Ali AU; Gomaa AS
    Australas J Dermatol; 2021 Aug; 62(3):e373-e379. PubMed ID: 33782959
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and Safety of Topical Therapy With Botanical Products for Melasma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Wang T; Wang Y; Wang J; Chen H; Qu B; Li Z
    Front Med (Lausanne); 2021; 8():797890. PubMed ID: 35141245
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decrypting the Potential of Nanotechnology-Based Approaches as Cutting-Edge for Management of Hyperpigmentation Disorder.
    Singh S; Sharma N; Zahoor I; Behl T; Antil A; Gupta S; Anwer MK; Mohan S; Bungau SG
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615414
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An efficacy study of 3 commercially available hydroquinone 4% treatments for melasma.
    Grimes PE
    Cutis; 2007 Dec; 80(6):497-502. PubMed ID: 18246882
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ultraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(27):1-66. PubMed ID: 23074532
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial.
    Adalatkhah H; Sadeghi-Bazargani H
    Drug Des Devel Ther; 2015; 9():4219-25. PubMed ID: 26345129
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lasers for treatment of melasma and post-inflammatory hyperpigmentation.
    Arora P; Sarkar R; Garg VK; Arya L
    J Cutan Aesthet Surg; 2012 Apr; 5(2):93-103. PubMed ID: 23060704
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hyperpigmentation Disorders in Hispanic Population in the United States.
    Rendon MI
    J Drugs Dermatol; 2019 Mar; 18(3):s112-114. PubMed ID: 30909363
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hyperpigmentation Disorders in Hispanic Population in the United States.
    Rendon MI
    J Drugs Dermatol; 2019 Mar; 18(3):s112-114. PubMed ID: 30909362
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and safety of adjuvant topical application of botanicals in the treatment of melasma: A systematic review and meta-analysis.
    Guo L; Zhang Y; Wu S; Bai M; Tian S; Miao M
    Heliyon; 2024 Mar; 10(6):e28096. PubMed ID: 38545140
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Melasma in people with darker skin types: a scoping review protocol on prevalence, treatment options for melasma and impact on quality of life.
    Mpofana N; Chibi B; Gqaleni N; Hussein A; Finlayson AJ; Kgarosi K; Dlova NC
    Syst Rev; 2023 Aug; 12(1):139. PubMed ID: 37563624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.